Bavarian Nordic
Anna Burakova is an experienced finance professional with a diverse background in various leadership roles across multiple organizations. Currently serving as the Head of Business Controlling and R&D Controller at Bavarian Nordic since September 2019, Anna has previously held positions including Finance Manager at Accord Healthcare and CFO at DMG MORI Russia. Additionally, Anna has worked as a Financial Controller at DMG MORI and Hochland and managed the Commercial department at Penoplex Holding. Anna's educational qualifications include an Executive MBA from TUM School of Management, a course in International Management & Intercultural cooperation from Tsinghua University, and a degree in Financial Management from National Mineral Resources University.
This person is not in any teams
This person is not in any offices
Bavarian Nordic
8 followers
Bavarian Nordic A/S is a biotechnology company specializing in research, development and manufacture of active cancer immunotherapies and vaccines for infectious diseases.